Search results
2 Billion More Reasons to Buy AbbVie Stock | The Motley Fool
The Motley Fool· 2 days agoThere are plenty of reasons to buy a leading biopharma business like AbbVie (ABBV -2.04%), and...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald ...
Kristin Chenoweth Says 'It's Wonderful to Find Your Person' After Marrying Josh Bryant: 'I Waited...
OK! Magazine· 2 days agoShe finally got that ring!
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie...
Benzinga· 6 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. ...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
The Parsons Sun· 7 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing ...
Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on ...
Monitoring Abbvie Inc (ABBV) after recent insider movements – Knox Daily
Knox Daily· 4 days agoAbbvie Inc’s filing revealed that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24. In the deal valued ...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 8 hours agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma, offering unique ...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 1 day agoThe targeted CD markets are highly competitive. If approved, Lilly will face stiff competition from ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoPortfolio companies have raised over US$ 600 million in equity capital. BASEL, Switzerland, May 22, 2024 /PRNewswire/ -- BaseLaunch, the Basel-based biotech venture incubator, today announces ...
